Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Claire Audrey-Bayan"'
Autor:
Patrizia Fuschiotti, Robert Lafyatis, James F. Conway, Claire-Audrey Bayan, Larisa J. Geskin, Tracy Tabib, Alyxzandria M. Gaydosik
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceecc972acef19814f6c96f364aa16a4
https://doi.org/10.1158/1078-0432.22471355.v1
https://doi.org/10.1158/1078-0432.22471355.v1
Autor:
Patrizia Fuschiotti, Robert Lafyatis, James F. Conway, Claire-Audrey Bayan, Larisa J. Geskin, Tracy Tabib, Alyxzandria M. Gaydosik
Purpose:The heterogeneity of tumor cells presents a major challenge to cancer diagnosis and therapy. Cutaneous T-cell lymphomas (CTCL) are a group of T lymphocyte malignancies that primarily affect skin. Lack of highly specific markers for malignant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d54e84dcea2de90119b56e69bdbf90cb
https://doi.org/10.1158/1078-0432.c.6527861
https://doi.org/10.1158/1078-0432.c.6527861
Autor:
Adriana Lopez, Larisa J. Geskin, Claire Audrey-Bayan, Megan H. Trager, Yvonne M. Saenger, Douglas K. Marks, Andrew M. Silverman, Emanuelle M. Rizk, Jaya Sarin Pradhan, Robyn D. Gartrell-Corrado, George W. Niedt
Publikováno v:
Melanoma research. 30(4)
Response to talimogene laherparepvec (T-Vec) is difficult to assess as pigmented macrophages that have ingested melanoma cells ('melanophages') persist after injection, mimicking melanoma. We used quantitative immunofluorescence (qIF) to (1) distingu
Publikováno v:
International Journal of Dermatology. 57:664-669
Background Dermatologic toxicity represents a substantial portion of all immune-related adverse events (irAEs) associated with PD-1/PD-L1 inhibitors. Bullous pemphigoid (BP) is a rare cutaneous side effect of these medications, which can initially be